The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts

References

• Alard, J., V. Lehrter, M. Rhimi, I. Mangin, V. Peucelle, A.-L. Abraham, M. Mariadassou, E. Maguin, A.-J. Waligora-Dupriet, B. Pot, et al. 2016. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environmental Microbiology 18 (5):1484–97. doi: 10.1111/1462-2920.13181.
   PubMed Web of Science ®Google Scholar
• Al-Assal, K., A. C. Martinez, R. S. Torrinhas, C. Cardinelli, and D. Waitzberg. 2018. Gut microbiota and obesity. Clinical Nutrition Experimental 20 (3):60–4. doi: 10.1016/j.yclnex.2018.03.001.
   Google Scholar
• Angelakis, E., F. Armougom, M. Million, and D. Raoult. 2012. The relationship between gut microbiota and weight gain in humans. Future Microbiology 7 (1):91–109. doi: 10.2217/fmb.11.142.
   PubMed Web of Science ®Google Scholar
• Bagarolli, R. A., N. Tobar, A. G. Oliveira, T. G. Araújo, B. M. Carvalho, G. Z. Rocha, J. F. Vecina, K. Calisto, D. Guadagnini, P. O. Prada, et al. 2017. Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice. The Journal of Nutritional Biochemistry 50 (12):16–25. doi: 10.1016/j.jnutbio.2017.08.006.
   PubMedGoogle Scholar
• Bailey, M. A., and H. D. Holscher. 2018. Microbiome-mediated effects of the Mediterranean diet on inflammation. Advances in Nutrition 9 (3):193–206. doi: 10.1093/advances/nmy013.
   PubMed Web of Science ®Google Scholar
• Bauer, P. V., S. C. Hamr, and F. A. Duca. 2016. Regulation of energy balance by a gut–brain axis and involvement of the gut microbiota. Cellular and Molecular Life Sciences 73 (4):737–55. doi: 10.1007/s00018-015-2083-z.
   PubMed Web of Science ®Google Scholar
• Bernini, L. J., A. N. C. Simão, D. F. Alfieri, M. A. B. Lozovoy, N. L. Mari, C. H. B. de Souza, I. Dichi, and G. N. Costa. 2016. Beneficial effects of Bifidobacterium lactis on lipid profile and cytokines in patients with metabolic syndrome: A randomized trial. Effects of probiotics on metabolic syndrome. Nutrition 32 (6):716–9. doi: 10.1016/j.nut.2015.11.001.
   PubMed Web of Science ®Google Scholar
• Bernini, L. J., A. N. C. Simão, C. H. B. Souza, D. F. Alfieri, L. G. Segura, G. N. Costa, and I. Dichi. 2018. Effect of Bifidobacterium lactis HN019 on inflammatory markers and oxidative stress in subjects with and without the metabolic syndrome. British Journal of Nutrition 120 (6):645–52. doi: 10.1017/S0007114518001861.
   PubMed Web of Science ®Google Scholar
• Beserra, B. T. S., R. Fernandes, V. A. Rosario, M. C. Mocellin, M. G. F. Kuntz, and E. B. S. M. Trindade. 2015. A systematic review and meta-analysis of the prebiotics and synbiotics effects on glycaemia, insulin concentrations and lipid parameters in adult patients with overweight or obesity. Clinical Nutrition 34 (5):845–58. doi: 10.1016/j.clnu.2014.10.004.
   PubMed Web of Science ®Google Scholar
• Bliss, E. S., and E. Whiteside. 2018. The gut-brain axis, the human gut microbiota and their integration in the development of obesity. Frontiers in Physiology 9 (7):1–27. doi: 10.3389/fphys.2018.00900.
   PubMedGoogle Scholar
• Bomhof, M. R., J. A. Parnell, H. R. Ramay, P. Crotty, K. P. Rioux, C. S. Probert, … R. A. Reimer. 2018. Histological improvement of non-alcoholic steatohepatitis with a prebiotic: A pilot clinical trial. European Journal of Nutrition 58 (4): 1735–1745. doi: 10.1007/s00394-018-1721-2.
   PubMed Web of Science ®Google Scholar
• Bomhof, M. R., D. C. Saha, D. T. Reid, H. A. Paul, and R. A. Reimer. 2014. Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity 22 (3):763–71. doi: 10.1002/oby.20632.
   PubMed Web of Science ®Google Scholar
• Borgeraas, H., L. K. Johnson, J. Skattebu, J. K. Hertel, and J. Hjelmesaeth. 2018. Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: A systematic review and meta-analysis of randomized controlled trials. Obesity Reviews 19 (2):219–32. doi: 10.1111/obr.12626.
   PubMed Web of Science ®Google Scholar
• Byrne, C. S., E. S. Chambers, D. J. Morrison, and G. Frost. 2015. The role of short chain fatty acids in appetite regulation and energy homeostasis. International Journal of Obesity 39 (9):1331–8. doi: 10.1038/ijo.2015.84.
   PubMed Web of Science ®Google Scholar
• Canfora, E. E., C. M. van der Beek, G. D.A. Hermes, G. H. Goossens, J. W.E. Jocken, J. J. Holst, H. M. van Eijk, K. Venema, H. Smidt, E. G. Zoetendal, et al. 2017. Supplementation of diet with galacto-oligosaccharides increases bifidobacteria, but not insulin sensitivity, in obese prediabetic individuals. Gastroenterology 153 (1):87–97. doi: 10.1053/j.gastro.2017.03.051.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., J. Amar, M. A. Iglesias, M. Poggi, C. Knauf, D. Bastelica, A. M. Neyrinck, F. Fava, K. M. Tuohy, C. Chabo, et al. 2007a. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56 (7):1761–72. doi: 10.2337/db06-1491.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., A. M. Neyrinck, F. Fava, C. Knauf, R. G. Burcelin, K. M. Tuohy, G. R. Gibson, and N. M. Delzenne. 2007b. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50 (11):2374–83. doi: 10.1007/s00125-007-0791-0.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., and N. M. Delzenne. 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Current Pharmaceutical Design 15 (13):1546–58. doi: 10.2174/138161209788168164.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., E. Lecourt, E. M. Dewulf, F. M. Sohet, B. D. Pachikian, D. Naslain, F. De Backer, A. M. Neyrinck, and N. M. Delzenne. 2009a. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. The American Journal of Clinical Nutrition 90 (5):1236–43. doi: 10.3945/ajcn.2009.28095.
   PubMed Web of Science ®Google Scholar
• Cani, P. D., S. Possemiers, T. Van de Wiele, Y. Guiot, A. Everard, O. Rottier, L. Geurts, D. Naslain, A. Neyrinck, D. M. Lambert, et al. 2009b. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58 (8):1091–103. doi: 10.1136/gut.2008.165886.
   PubMed Web of Science ®Google Scholar
• Cano, P. G., A. Santacruz, F. M. Trejo, and Y. Sanz. 2013. Bifidobacterium CECT 7765 improves metabolic and immunological alterations associated with obesity in high-fat diet-fed mice. Obesity 21 (11):2310–21. doi: 10.1002/oby.20330.
   PubMed Web of Science ®Google Scholar
• Chen, Y. T., N. S. Yang, Y. C. Lin, S. T. Ho, K. Y. Li, J. S. Lin, … M. J. Chen. 2018. A combination of Lactobacillus mali APS1 and dieting improved the efficacy of obesity treatment via manipulating gut microbiome in mice. Nature Scientific Report 8 (6153):1–14.
   PubMedGoogle Scholar
• Clemente, J. C., J. Manasson, and J. U. Scher. 2018. The role of the gut microbiome in systemic inflammatory disease. British Medical Journal 360:j5145. doi: 10.1136/bmj.j5145.
   PubMedGoogle Scholar
• Crovesy, L., M. Ostrowski, D. M. T. P. Ferreira, E. L. Rosado, and M. Soares-Mota. 2017. Effect of Lactobacillus on body weight and body fat in overweight subjects: A systematic review of randomized controlled clinical trials. International Journal of Obesity 41 (11):1607–14. doi: 10.1038/ijo.2017.161.
   Web of Science ®Google Scholar
• Daguet, D,. I. Pinheiro, A. Verhelst, S. Possemiers, and M. Marzorati. 2016. Arabinogalactan and fructooligosaccharides improve the gut barrier function in distinct areas of the colon in the Simulator of the Human Intestinal Microbial Ecosystem. Journal of Functional Foods 20:369–79. doi: 10.1016/j.jff.2015.11.005.
   Web of Science ®Google Scholar
• Dao, M. C., and K. Clement. 2018. Gut microbiota and obesity: Concepts relevant to clinical care. European Journal of Internal Medicine 48 (2):18–24. doi: 10.1016/j.ejim.2017.10.005.
   PubMedGoogle Scholar
• Delgado, G. T. C., and W. M. S. C. Tamashiro. 2018. Role of prebiotics in regulation of microbiota and prevention of obesity. Food Research International 113 (7):183–8. doi: 10.1016/j.foodres.2018.07.013.
   PubMedGoogle Scholar
• Depommier, C., A. Everard, C. Druart, H. Plovier, M. Van Hul, S. Vieira-Silva, G. Falony, J. Raes, D. Maiter, N. M. Delzenne, et al. 2019. Supplemenation with Akkermansia muciniphila in overweight and obese human volunteers: A proof-of-concept exploratory study. Nature Medicine 25 (7):1096–103. doi: 10.1038/s41591-019-0495-2.
   PubMed Web of Science ®Google Scholar
• Dewulf, E. M., P. D. Cani, S. P. Claus, S. Fuentes, P. G. Puylaert, A. M. Neyrinck, L. B. Bindels, W. M. de Vos, G. R. Gibson, J. P. Thissen, et al. 2013. Insight into the prebiotic concept: Lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62 (8):1112–21., doi: 10.1136/gutjnl-2012-303304.
   PubMed Web of Science ®Google Scholar
• Doria, E., E. Buonocore, A. Michelotti, V. Nobile, and F. Marzatico. 2013. Evaluation of a phyto-supplement efficacy as adjuvant in reducing body weight and fat mass in overweight women. Current Topics in Nutraceutical Research 11 (1–2):21–8.
   Web of Science ®Google Scholar
• Dror, T., Y. Dickstein, G. Dubourg, and M. Paul. 2017. Microbiota manipulation for weight change. Microbial Pathogenesis 106 (5):146–61. doi: 10.1016/j.micpath.2016.01.002.
   PubMedGoogle Scholar
• Ebrahimi, Z. S., E. Nasli-Esfahani, A. Nadjarzade, and H. Mozaffari-Khosravi. 2017. Effect of symbiotic supplementation on glycemic control, lipid profiles and microalbuminuria in patients with non-obese type 2 diabetes: A randomized, double-blind, clinical trial. Journal of Diabetes and Metabolic Disorders 16 (23):1–10.
   PubMedGoogle Scholar
• Everard, A., V. Lazarevic, N. Gaïa, M. Johansson, M. Ståhlman, F. Backhed, N. M. Delzenne, J. Schrenzel, P. François, and P. D. Cani. 2014. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. The ISME Journal 8 (10):2116–30. doi: 10.1038/ismej.2014.45.
   PubMed Web of Science ®Google Scholar
• Falcinelli, S., A. Rodiles, A. Hatef, S. Picchietti, L. Cossignani, D. L. Merrifield, S. Unniappan, and O. Carnevali. 2018. Influence of probiotics administration on gut microbiota core: A review on the effects on appetite control, glucose, and lipid metabolism. Journal of Clinical Gastroenterology 52 (11):S50–S56. doi: 10.1097/MCG.0000000000001064.
   PubMedGoogle Scholar
• FDA. 2020. GRAS notice. Accessed January 30, 2020. https://www.accessdata.fda.gov/scripts/fdcc/?set=GRASNotices.
   Google Scholar
• Forssten, S. D., M. Z. Korczyńska, R. M.L. Zwijsen, W. H. Noordman, M. Madetoja, and A. C. Ouwehand. 2013. Changes in satiety hormone concentrations and feed intake in rats in response to lactic acid bacteria. Appetite 71 (12):16–21. doi: 10.1016/j.appet.2013.06.093.
   PubMedGoogle Scholar
• Foxx-Orenstein, A. E., and W. D. Chey. 2012. Manipulation of the gut microbiota as a novel treatment strategy for gastrointestinal disorders. The American Journal of Gastroenterology Supplements 1 (1):41–6. doi: 10.1038/ajgsup.2012.8.
   Google Scholar
• Gauffin-Cano, P., A. Santacruz, Á. Moya, and Y. Sanz. 2012. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PloS One. 7 (7):1–16. doi: 10.1371/journal.pone.0041079.
   Web of Science ®Google Scholar
• Gibson, R. A., D. Barclay, H. Marshall, J. Moulin, J. C. Maire, and M. Makrides. 2009. Safety of supplementing infant formula with long-chain polyunsaturated fatty acids and Bifidobacterium lactis in term infants: A randomised controlled trial. British Journal of Nutrition 101 (11):1706–13. doi: 10.1017/S0007114508084080.
   PubMed Web of Science ®Google Scholar
• Gibson, G. R., R. Hutkins, M. E. Sanders, S. L. Prescott, R. A. Reimer, S. J. Salminen, … G. Reid. 2017. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Prebiotics. Nature Reviews Gastroenterology & Hepatology 4 (8):491–502. doi: 10.1038/nrgastro.2017.75.
   Google Scholar
• Gomes, A. C., R. G. M. Sousa, P. B. Botelho, T. L. N. Gomes, P. O. Prada, and J. F. Mota. 2017. The additional effects of a probiotic mix on abdominal adiposity and antioxidant status: A double-blind, randomized trial. Obesity 25 (1):30–8. doi: 10.1002/oby.21671.
   PubMed Web of Science ®Google Scholar
• Hadi, A., K. Alizadeh, H. Hajianfar, H. Mohammadi, and M. Miraghajani. 2020. Efficacy of synbiotic supplementation in obesity treatment: A systematic review and meta-analysis of clinical trials. Critical Reviews in Food Science and Nutrition 60 (4):584–96. doi: 10.1080/10408398.2018.1545218.
   PubMed Web of Science ®Google Scholar
• Han, Y., and H. Xiao. 2020. Whole food-based approaches to modulating gut microbiota and associated diseases. Annual Review of Food Science and Technology 11 (1):14.1–.25. doi: 10.1146/annurev-food-111519-014337.
   Google Scholar
• Henrique-Bana, F. C., X. Wang, G. N. Costa, W. A. Spinosa, L. H.S. Miglioranza, E. Scorletti, P. C. Calder, C. D. Byrne, and G. R. Gibson. 2020. In vitro effects of Bifidobacterium lactis-based synbiotics on human faecal bacteria. Food Research International 128:108776. doi: 10.1016/j.foodres.2019.108776.
   PubMed Web of Science ®Google Scholar
• Higashikawa, F., M. Noda, T. Awaya, N. Danshiitsoodol, Y. Matoba, T. Kumagai, and M. Sugiyama. 2016. Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: A randomized, double-blind, placebo-controlled clinical trial. European Journal of Clinical Nutrition 70 (5):582–7. doi: 10.1038/ejcn.2016.17.
   PubMed Web of Science ®Google Scholar
• Hill, C., F. Guarner, G. Reid, G. R. Gibson, D. J. Merenstein, B. Pot, L. Morelli, R. B. Canani, H. J. Flint, S. Salminen, et al. 2014. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews Gastroenterology & Hepatology 11 (8):506–14., doi: 10.1038/nrgastro.2014.66.
   PubMed Web of Science ®Google Scholar
• Hugon, P., J. C. Lagier, P. Colson, F. Bittar, and D. Raoult. 2017. Repertoire of human gut microbes. Microbial Pathogenesis 106:103–12. doi: 10.1016/j.micpath.2016.06.020.
   PubMed Web of Science ®Google Scholar
• Javadi, L., M. Ghavami, M. Khoshbaten, A. Safaiyan, A. Barzegari, and B. P. Gargari. 2017. The potential role of probiotics or/and prebiotic on serum lipid profile and insulin resistance in alcoholic fatty liver disease: A double blind randomized clinical trial. Crescent Journal of Medical and Biological Sciences 4 (3):131–8.
   Web of Science ®Google Scholar
• John, G. K., L. Wang, J. Nanavati, C. Twose, R. Singh, and G. Mullin. 2018. Dietary alteration of the gut microbiome and its impact on weight and fat mass: A systematic review and meta-analysis. Genes 9 (3):167–19. doi: 10.3390/genes9030167.
   PubMed Web of Science ®Google Scholar
• Jones, R. B., T. L. Alderete, A. A. Martin, B. A. Geary, D. H. Hwang, S. L. Palmer, and M. I. Goran. 2018. Probiotic supplementation increases obesity with no detectable effects on liver fat or gut microbiota in obese Hispanic adolescents: A 16-week, randomized, placebo-controlled trial. Pediatric Obesity 13 (11):705–14. doi: 10.1111/ijpo.12273.
   PubMed Web of Science ®Google Scholar
• Jung, S. P., K. M. Lee, J. H. Kang, S. I. Yun, H. O. Park, Y. Moon, and J. Y. Kim. 2013. Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial. Korean Journal of Family Medicine 34 (2):80–9. doi: 10.4082/kjfm.2013.34.2.80.
   PubMedGoogle Scholar
• Jung, S., Y. J. Lee, M. Kim, M. Kim, J. H. Kwak, J. W. Lee, Y. T. Ahn, J. H. Sim, and J. H. Lee. 2015. Supplementation with two probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032, reduced body adiposity and Lp-PLA2 activity in overweight subjects. Journal of Functional Foods 19 (10):744–52. doi: 10.1016/j.jff.2015.10.006.
   Google Scholar
• Kadooka, Y., M. Sato, K. Imaizumi, A. Ogawa, K. Ikuyama, Y. Akai, M. Okano, M. Kagoshima, and T. Tsuchida. 2010. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 64 (6):636–43. doi: 10.1038/ejcn.2010.19.
   PubMed Web of Science ®Google Scholar
• Kadooka, Y., M. Sato, A. Ogawa, M. Miyoshi, H. Uenishi, H. Ogawa, K. Ikuyama, M. Kagoshima, and T. Tsuchida. 2013. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition 110 (9):1696–703. doi: 10.1017/S0007114513001037.
   PubMed Web of Science ®Google Scholar
• Karaki, S., H. Tazoe, H. Hayashi, H. Kashiwabara, K. Tooyama, Y. Suzuki, and A. Kuwahara. 2008. Expression of the short-chain fatty acid receptor, GPR43, in the human colon. Journal of Molecular Histology 39 (2):135–42. doi: 10.1007/s10735-007-9145-y.
   PubMed Web of Science ®Google Scholar
• Kellow, N. J., M. T. Coughlan, and C. M. Reid. 2014. Metabolic benefits of dietary prebiotics in human subjects: A systematic review of randomised controlled trials. British Journal of Nutrition 111 (7):1147–61. doi: 10.1017/S0007114513003607.
   PubMed Web of Science ®Google Scholar
• Kobyliak, N., C. Conte, G. Cammarota, A. P. Haley, I. Styriak, L. Gaspar, J. Fusek, L. Rodrigo, and P. Kruzliak. 2016. Probiotics in prevention and treatment of obesity: A critical view. Nutrition & Metabolism 13 (14):14–3. doi: 10.1186/s12986-016-0067-0.
   PubMedGoogle Scholar
• Kobyliak, N., T. Falalyeyeva, N. Boyko, O. Tsyryuk, T. Beregova, and L. Ostapchenko. 2018. Probiotics and nutraceuticals as a new frontier in obesity prevention and management. Diabetes Research and Clinical Practice 141 (5):190–9. doi: 10.1016/j.diabres.2018.05.005.
   PubMedGoogle Scholar
• Lam, Y. Y., S. Maguire, T. Palacios, and I. D. Caterson. 2017. Are the gut bacteria telling us to eat or not to eat? reviewing the role of gut microbiota in the etiology, disease progression and treatment of eating disorders. Nutrients 9 (6):602–15. doi: 10.3390/nu9060602.
   PubMed Web of Science ®Google Scholar
• Le Chatelier, E., T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, G. Falony, M. Almeida, M. Arumugam, J.-M. Batto, S. Kennedy, et al. 2013. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (7464):541–6. doi: 10.1038/nature12506.
   PubMed Web of Science ®Google Scholar
• Leber, B., N. J. Tripolt, D. Blattl, M. Eder, T. C. Wascher, T. R. Pieber, R. Stauber, H. Sourij, K. Oettl, and V. Stadlbauer. 2012. The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: An open label, randomized pilot study. European Journal of Clinical Nutrition 66 (10):1110–5. doi: 10.1038/ejcn.2012.103.
   PubMed Web of Science ®Google Scholar
• Lee, S. J., S. Bose, J. G. Seo, W. S. Chung, C. Y. Lim, and H. Kim. 2014. The effects of co-administration of probiotics with herbal medicine on obesity, metabolic endotoxemia and dysbiosis: A randomized double-blind controlled clinical trial. Clinical Nutrition 33 (6):973–81. doi: 10.1016/j.clnu.2013.12.006.
   PubMed Web of Science ®Google Scholar
• Liu, F., X. Wang, H. Shi, Y. Wang, C. Xue, and Q. J. Tang. 2017. Polymannuronic acid ameliorated obesity and inflammation associated with a high-fat and high-sucrose diet by modulating the gut microbiome in a murine model. British Journal of Nutrition 117 (9):1332–42. doi: 10.1017/S0007114517000964.
   PubMed Web of Science ®Google Scholar
• Luu, M., and A. Visekruna. 2019. Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells. European Journal of Immunology 49 (6):842–8. doi: 10.1002/eji.201848009.
   PubMed Web of Science ®Google Scholar
• Madjd, A., M. A. Taylor, N. Mousavi, A. Delavari, R. Malekzadeh, I. A. Macdonald, and H. R. Farshchi. 2016. Comparison of the effect of daily consumption of probiotic compared with low-fat conventional yogurt on weight loss in healthy obese women following an energy-restricted diet: A randomized controlled trial. The American Journal of Clinical Nutrition 103 (2):323–9. doi: 10.3945/ajcn.115.120170.
   PubMed Web of Science ®Google Scholar
• Makki, K., E. C. Deehan, J. Walter, and F. Bäckhed. 2018. The impact of dietary fiber on gut microbiota in host health and disease. Cell Host & Microbe 23 (6):705–15. doi: 10.1016/j.chom.2018.05.012.
   PubMed Web of Science ®Google Scholar
• Minami, J., S. Kondo, N. Yanagisawa, T. Odamaki, J. Z. Xiao, F. Abe, … T. Shimoda. 2015. Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial. Journal of Nutrition Science 4 (e17):1–7.
   Google Scholar
• Mischke, M., T. Arora, S. Tims, E. Engels, N. Sommer, K. van Limpt, A. Baars, R. Oozeer, A. Oosting, F. Bäckhed, et al. 2018. Specific synbiotics in early life protect against diet-induced obesity in adult mice. Diabetes, Obesity and Metabolism 20 (6):1408–18. doi: 10.1111/dom.13240.
   PubMed Web of Science ®Google Scholar
• Miyoshi, M., A. Ogawa, S. Higurashi, and Y. Kadooka. 2014. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice. European Journal of Nutrition 53 (2):599–606. doi: 10.1007/s00394-013-0568-9.
   PubMed Web of Science ®Google Scholar
• Mulders, R. J., K. C. G. de Git, E. Schéle, S. L. Dickson, Y. Sanz, and R. A. H. Adan. 2018. Microbiota in obesity: Interactions with enteroendocrine, immune and central nervous systems. Obesity Reviews 19 (4):435–51. doi: 10.1111/obr.12661.
   PubMed Web of Science ®Google Scholar
• Neyrinck, A. M., V. L. Schüppel, T. Lockett, D. Haller, and N. M. Delzenne. 2016. Microbiome and metabolic disorders related to obesity: Which lessons to learn from experimental models?. Trends in Food Science & Technology 57 (8):256–64. doi: 10.1016/j.tifs.2016.08.012.
   Google Scholar
• Nicolucci, A. C., M. P. Hume, I. Martínez, S. Mayengbam, J. Walter, and R. A. Reimer. 2017. Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity. Gastroenterology 153 (3):711–22. doi: 10.1053/j.gastro.2017.05.055.
   PubMed Web of Science ®Google Scholar
• Nie, Y., F. Luo, and Q. Lin. 2018. Dietary nutrition and gut microflora: A promising target for treating diseases. Trends in Food Science & Technology 75 (3):72–80. doi: 10.1016/j.tifs.2018.03.002.
   Google Scholar
• Nikbakht, E., S. Khalesi, I. Singh, L. T. Williams, N. P. West, and N. Colson. 2018. Effect of probiotics and synbiotics on blood glucose: A systematic review and meta - analysis of controlled trials. European Journal of Nutrition 57 (1):95–106. doi: 10.1007/s00394-016-1300-3.
   PubMed Web of Science ®Google Scholar
• Park, D. Y., Y. T. Ahn, S. H. Park, C. S. Huh, S. R. Yoo, R. Yu, et al. 2013. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PloS One. 8 (7):1–12. doi: 10.1371/journal.pone.0059470.
   Google Scholar
• Patterson, E., P. M. Ryan, J. F. Cryan, T. G. Dinan, R. P. Ross, G. F. Fitzgerald, and C. Stanton. 2016. Gut microbiota, obesity and diabetes. Postgraduate Medical Journal 92 (1087):286–300. doi: 10.1136/postgradmedj-2015-133285.
   PubMed Web of Science ®Google Scholar
• Paul, H. A., M. R. Bomhof, H. J. Vogel, and R. A. Reimer. 2016. Diet-induced changes in maternal gut microbiota and metabolomic profiles influence programming of offspring obesity risk in rats. Scientific Reports 12 (6):1–14. doi: 10.1038/srep20683.
   Google Scholar
• Poutahidis, T., M. Kleinewietfeld, C. Smillie, T. Levkovich, A. Perrotta, S. Bhela, B. J. Varian, Y. M. Ibrahim, J. R. Lakritz, S. M. Kearney, et al. 2013. Microbial reprogramming inhibits Western diet-associated obesity. PloS One. 8 (7):e68596–11. doi: 10.1371/journal.pone.0068596.
   PubMed Web of Science ®Google Scholar
• Probert, H. M., J. H. A. Apajalahti, N. Rautonen, J. Stowell, and G. R. Gibson. 2004. Polydextrose, lactitol, and fructo-oligosaccharide fermentation by colonic bacteria in a three-stage continuous culture system. Applied and Environmental Microbiology 70 (8):4505–11. doi: 10.1128/AEM.70.8.4505-4511.2004.
   PubMed Web of Science ®Google Scholar
• Rabiei, S., M. Hedayati, B. Rashidkhani, N. Saadat, and R. Shakerhossini. 2018. The effects of synbiotic supplementation on body mass index, metabolic and inflammatory biomarkers, and appetite in patients with metabolic syndrome: A triple-blind randomized controlled trial. Journal of Dietary Supplements 1 (2:6):1–13. doi: 10.1080/19390211.2018.1455788.
   Google Scholar
• Rastelli, M., C. Knauf, and P. D. Cani. 2018. Gut microbes and health: A focus on the mechanisms linking microbes, obesity, and related disorders. Obesity 26 (5):792–800. doi: 10.1002/oby.22175.
   PubMed Web of Science ®Google Scholar
• Rebello, C. J., J. Burton, M. Heiman, and F. L. Greenway. 2015. Gastrointestinal microbiome modulator improves glucose tolerance in overweight and obese subjects: A randomized controlled pilot trial. Journal of Diabetes and Its Complications 29 (8):1272–6. doi: 10.1016/j.jdiacomp.2015.08.023.
   PubMed Web of Science ®Google Scholar
• Reimer, R. A., H. J. Willis, J. M. Tunnicliffe, H. Park, K. L. Madsen, and A. Soto-Vaca. 2017. Inulin-type fructans and whey protein both modulate appetite but only fructans alter gut microbiota in adults with overweight/obesity: A randomized controlled trial. Molecular Nutrition & Food Research 61 (11):1700484. doi: 10.1002/mnfr.201700484.
   Web of Science ®Google Scholar
• Rezazadeh, L., B. P. Gargari, M. A. Jafarabadi, and B. Alipour. 2019. Effects of probiotic yogurt on glycemic indexes and endothelial dysfunction markers in patients with metabolic syndrome. Nutrition 62:162–8. doi: 10.1016/j.nut.2018.12.011.
   PubMed Web of Science ®Google Scholar
• Ricci, A., A. Allende, D. Bolton, M. Chemaly, R. Davies, R. Girones, et al. 2017. Scientific opinion on the update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA. EFSA Journal 15 (3):4664. doi: 10.2903/j.efsa.2017.4884.
   Web of Science ®Google Scholar
• Ross, P., S. Mills, C. Hill, G.F. Fitzgerald, and C. Stanton. 2010. Specific metabolite production by gut microbiota as a basis for probiotic function. International Dairy Journal 20 (4):269–76. doi: 10.1016/j.idairyj.2009.12.003.
   Web of Science ®Google Scholar
• Salazar, N., E. M. Dewulf, A. M. Neyrinck, L. B. Bindels, P. D. Cani, J. Mahillon, W. M. de Vos, J. P. Thissen, M. Gueimonde, C. G. de los Reyes-Gavilán, et al. 2015. Inulin-type fructans modulate intestinal Bifidobacterium species populations and decrease fecal short-chain fatty acids in obese women. Clinical Nutrition 34 (3):501–7., doi: 10.1016/j.clnu.2014.06.001.
   PubMed Web of Science ®Google Scholar
• Sanchez, M., C. Darimont, V. Drapeau, S. Emady-Azar, M. Lepage, E. Rezzonico, C. Ngom-Bru, B. Berger, L. Philippe, C. Ammon-Zuffrey, et al. 2014. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. British Journal of Nutrition 111 (8):1507–19. doi: 10.1017/S0007114513003875.
   PubMed Web of Science ®Google Scholar
• Sayin, S. I., A. Wahlström, J. Felin, S. Jäntti, H.-U. Marschall, K. Bamberg, B. Angelin, T. Hyötyläinen, M. Orešič, and F. Bäckhed. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metabolism 17 (2):225–35. doi: 10.1016/j.cmet.2013.01.003.
   PubMed Web of Science ®Google Scholar
• Seganfredo, F. B., C. A. Blume, M. Moehlecke, A. Giongo, D. S. Casagrande, J. V. N. Spolidoro, A. V. Padoin, B. D. Schaan, and C. C. Mottin. 2017. Weight-loss interventions and gut microbiota changes in overweight and obese patients: A systematic review. Obesity Reviews 18 (8):832–51. doi: 10.1111/obr.12541.
   PubMed Web of Science ®Google Scholar
• Sergeev, I. N., T. Aljutaily, G. Walton, and E. Huarte. 2020. Effects of synbiotic supplement on human gut microbiota, body composition and weight loss in obesity. Nutrients 12 (1):222. doi: 10.3390/nu12010222.
   PubMed Web of Science ®Google Scholar
• Sharafedtinov, K. K., O. A. Plotnikova, R. I. Alexeeva, T. B. Sentsova, E. Songisepp, J. Stsepetova, I. Smidt, and M. Mikelsaar. 2013. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients - a randomized double-blind placebo-controlled pilot study. Nutrition Journal 12 (1):138. doi: 10.1186/1475-2891-12-138.
   PubMedGoogle Scholar
• Sroka‐Oleksiak, A., A. Mlodzinska, M. Bulanda, D. Salamon, P. Major, M. Stanek, and T. Gosiewski. 2020. Metagenomic analysis of duodenal microbiota reveals a potential biomarker of dysbiosis in the course of obesity and type 2 diabetes: A pilot study. Journal of Clinical Medicine 9:369. doi: 10.3390/jcm9020369.
   Web of Science ®Google Scholar
• Stenman, L. K., M. J. Lehtinen, N. Meland, J. E. Christensen, N. Yeung, M. T. Saarinen, M. Courtney, R. Burcelin, M.-L. Lähdeaho, J. Linros, et al. 2016. Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults-randomized controlled trial. EBioMedicine 13 (10):190–200. doi: 10.1016/j.ebiom.2016.10.036.
   PubMedGoogle Scholar
• Szulińska, M., I. Łoniewski, S. Van Hemert, M. Sobieska, and P. Bogdański. 2018. Dose-dependent effects of multispecies probiotic supplementation on the lipopolysaccharide (LPS) level and cardiometabolic profile in obese postmenopausal women: A 12-week randomized clinical trial. Nutrients 10 (6):1–16. doi: 10.3390/nu10060773.
   Web of Science ®Google Scholar
• Tenorio-Jiménez, C., M. J. Martínez-Ramírez, I. Del Castillo-Codes, C. Arraiza-Irigoyen, M. Tercero-Lozano, J. Camacho, N. Chueca, F. García, J. Olza, J. Plaza-Díaz, et al. 2019. Lactobacillus reuteri V3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome: The PROSIR Study. Nutrients 11 (8):1761., doi: 10.3390/nu11081761.
   Web of Science ®Google Scholar
• Tolhurst, G., H. Heffron, Y. S. Lam, H. E. Parker, A. M. Habib, E. Diakogiannaki, J. Cameron, J. Grosse, F. Reimann, and F. M. Gribble. 2012. Short-chain fatty acids stimulate Glucagon-like Peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes 61 (2):364–71. doi: 10.2337/db11-1019.
   PubMed Web of Science ®Google Scholar
• Toral, M., M. Gómez-Guzmán, R. Jiménez, M. Romero, M. Sánchez, M. P. Utrilla, N. Garrido-Mesa, M. E. Rodríguez-Cabezas, M. Olivares, J. Gálvez, et al. 2014. The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. Clinical Science 127 (1):33–45. doi: 10.1042/CS20130339.
   PubMed Web of Science ®Google Scholar
• Torres, S., E. Fabersani, A. Marquez, and P. Gauffin-Cano. 2018. Adipose tissue inflammation and metabolic syndrome. The proactive role of probiotics. European Journal of Nutrition. doi: 10.1007/s00394-018-1790-2.
   Web of Science ®Google Scholar
• Torres-Fuentes, C., H. Schellekens, T. G. Dinan, and J. F. Cryan. 2017. The microbiota–gut–brain axis in obesity. The Lancet Gastroenterology & Hepatology 2 (10):747–56. doi: 10.1016/S2468-1253(17)30147-4.
   PubMed Web of Science ®Google Scholar
• Torres-Fuentes, C., H. Schellekens, T. G. Dinan, and J. F. Cryan. 2015. A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review. Nutritional Neuroscience 18 (2):49–65. doi: 10.1179/1476830513Y.0000000099.
   PubMed Web of Science ®Google Scholar
• van der Beek, C. M., E. E. Canfora, A. M. Kip, S. H.M. Gorissen, S. W.M. Olde Damink, H. M. van Eijk, J. J. Holst, E. E. Blaak, C. H.C. Dejong, and K. Lenaerts. 2018. The prebiotic inulin improves substrate metabolism and promotes short chain fatty acid production in overweight to obese men. Metabolism Clinical Metabolism 87 (10):25–35. doi: 10.1016/j.metabol.2018.06.009.
   PubMedGoogle Scholar
• Velikonja, A., L. Lipoglavšek, M. Zorec, R. Orel, and G. Avguštin. 2019. Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development. Anaerobe 55:67–77. doi: 10.1016/j.anaerobe.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Vinolo, M. A. R., H. G. Rodrigues, R. T. Nachbar, and R. Curi. 2011. Regulation of inflammation by short chain fatty acids. Nutrients 3 (10):858–76. doi: 10.3390/nu3100858.
   PubMed Web of Science ®Google Scholar
• Wanchai, K., S. Yasom, W. Tunapong, T. Chunchai, S. Eaimworawuthikul, P. Thiennimitr, C. Chaiyasut, A. Pongchaidecha, V. Chatsudthipong, S. Chattipakorn, et al. 2018. Probiotic Lactobacillus paracasei HII01 protects rats against obese-insulin resistance-induced kidney injury and impaired renal organic anion transporter 3 function. Clinical Science 132 (14):1545–63. doi: 10.1042/CS20180148.
   PubMed Web of Science ®Google Scholar
• Watanabe, M., K. Morimoto, S. M. Houten, N. Kaneko-Iwasaki, T. Sugizaki, Y. Horai, C. Mataki, H. Sato, K. Murahashi, E. Arita, et al. 2012. Bile acid binding resin improves metabolic control through the induction of energy expenditure. Plos One. 7 (8):e38286–9. doi: 10.1371/journal.pone.0038286.
   PubMed Web of Science ®Google Scholar
• WHO (World Health Organization). 2018. Obesity and overweight. Fact sheet No 311. Geneva, Switzerland. http://www.who.int/mediacentre/factsheets/fs311/en/.
   Google Scholar
• Yadav, H., J. H. Lee, J. Lloyd, P. Walter, and S. G. Rane. 2013. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry 288 (35):25088–97. doi: 10.1074/jbc.M113.452516.
   PubMed Web of Science ®Google Scholar
• Yan, S., Z. Tian, M. Li, B. Li, and W. Cui. 2019. Effects of probiotic supplementation on the regulation of blood lipid levels in overweight or obese subjects: A meta-analysis. Food & Function 10 (3):1747–59. doi: 10.1039/C8FO02163E.
   PubMed Web of Science ®Google Scholar
• Zarrati, M., E. Salehi, K. Nourijelyani, V. Mofid, M. J. H. Zadeh, F. Najafi, Z. Ghaflati, K. Bidad, M. Chamari, M. Karimi, et al. 2014. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without weight-loss diet. Journal of the American College of Nutrition 33 (6):417–25. doi: 10.1080/07315724.2013.874937.
   PubMed Web of Science ®Google Scholar
• Zhang, T., Q. Li, L. Cheng, H. Buch, and F. Zhang. 2019. Akkermansia muciniphila is a promising probiotic. Microbial Biotechnology 12 (6):1109–25. doi: 10.1111/1751-7915.13410.
   PubMed Web of Science ®Google Scholar
• Zhi, C., J. Huang, J. Wang, H. Cao, Y. Bai, J. Guo, and Z. Su. 2019. Connection between gut microbiome and the development of obesity. European Journal of Clinical Microbiology & Infectious Diseases 38:1987–98. doi: 10.1007/s10096-019-03623-x.
   PubMed Web of Science ®Google Scholar